[go: up one dir, main page]

NO3050055T3 - - Google Patents

Info

Publication number
NO3050055T3
NO3050055T3 NO14781027A NO14781027A NO3050055T3 NO 3050055 T3 NO3050055 T3 NO 3050055T3 NO 14781027 A NO14781027 A NO 14781027A NO 14781027 A NO14781027 A NO 14781027A NO 3050055 T3 NO3050055 T3 NO 3050055T3
Authority
NO
Norway
Application number
NO14781027A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO3050055T3 publication Critical patent/NO3050055T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16641Use of virus, viral particle or viral elements as a vector
    • C12N2710/16643Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16651Methods of production or purification of viral material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO14781027A 2013-01-08 2014-09-26 NO3050055T3 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361750175P 2013-01-08 2013-01-08

Publications (1)

Publication Number Publication Date
NO3050055T3 true NO3050055T3 (no) 2018-02-10

Family

ID=51167323

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14781027A NO3050055T3 (no) 2013-01-08 2014-09-26

Country Status (20)

Country Link
US (2) US11299715B2 (no)
EP (3) EP3521420A1 (no)
JP (2) JP6534933B2 (no)
KR (1) KR102307279B1 (no)
CN (1) CN105008523B (no)
AR (1) AR094389A1 (no)
AU (1) AU2014205604B2 (no)
BR (2) BR122020002822B1 (no)
CA (1) CA2897444A1 (no)
DK (1) DK2943567T3 (no)
ES (1) ES2651763T3 (no)
HK (2) HK1214840A1 (no)
HU (1) HUE037482T2 (no)
IL (1) IL239824B (no)
MX (1) MX360470B (no)
NO (1) NO3050055T3 (no)
RU (1) RU2676733C2 (no)
SG (3) SG10201806715TA (no)
TW (1) TWI608102B (no)
WO (1) WO2014110053A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10335466B2 (en) 2014-11-05 2019-07-02 Voyager Therapeutics, Inc. AADC polynucleotides for the treatment of parkinson's disease
CN112410339A (zh) 2014-11-14 2021-02-26 沃雅戈治疗公司 调节性多核苷酸
JP2017535266A (ja) 2014-11-14 2017-11-30 ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. 筋萎縮性側索硬化症(als)を治療する組成物および方法
WO2016094783A1 (en) 2014-12-12 2016-06-16 Voyager Therapeutics, Inc. Compositions and methods for the production of scaav
US11013774B2 (en) 2016-03-28 2021-05-25 Ultragenyx Pharmaceutical Inc. Methods of heat inactivation of adenovirus
RU2758488C2 (ru) 2016-05-18 2021-10-28 Вояджер Терапьютикс, Инк. Модулирующие полинуклеотиды
US11795473B2 (en) 2016-10-14 2023-10-24 Ultragenyx Pharmaceutical Inc. Use of tonicifying agents to enhance recombinant adeno-associated virus yield
US11898170B2 (en) 2017-03-22 2024-02-13 Ultragenyx Pharmaceutical Inc. Cell culture methods involving HDAC inhibitors or rep proteins
JOP20190269A1 (ar) 2017-06-15 2019-11-20 Voyager Therapeutics Inc بولي نوكليوتيدات aadc لعلاج مرض باركنسون
CN110835622B (zh) * 2018-08-16 2021-04-27 上海药明生物技术有限公司 用于调节哺乳动物细胞乳酸代谢的培养基及其应用
IL296258A (en) 2020-03-16 2022-11-01 Ultragenyx Pharmaceutical Inc Methods for enhancing recombinant adeno-associated virus yield
WO2023157976A1 (ja) * 2022-02-21 2023-08-24 学校法人日本医科大学 ウイルスベクター生産性増強剤及びウイルスベクターの製造方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
AU8200191A (en) 1990-07-09 1992-02-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The High efficiency packaging of mutant adeno-associated virus using amber suppressions
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
RU2012335C1 (ru) 1991-07-04 1994-05-15 Уфимский научно-исследовательский институт глазных болезней Ингибитор вируса простого герпеса
AU663725B2 (en) 1991-08-20 1995-10-19 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Adenovirus mediated transfer of genes to the gastrointestinal tract
US7223411B1 (en) 1992-07-31 2007-05-29 Dana-Farber Cancer Institute Herpesvirus replication defective mutants
WO1994003207A1 (en) 1992-07-31 1994-02-17 President And Fellows Of Harvard College Herpesvirus vaccines
US6833271B2 (en) 1996-12-04 2004-12-21 Medi-Cult A/S Serum-free cell culture media
GB9816856D0 (en) 1998-08-03 1998-09-30 Univ London Cell lines for virus growth
US6783972B1 (en) * 1998-09-22 2004-08-31 University Of Florida Research Foundation Methods for large-scale production of recombinant AAV vectors
US6593123B1 (en) 2000-08-07 2003-07-15 Avigen, Inc. Large-scale recombinant adeno-associated virus (rAAV) production and purification
US7091029B2 (en) 2002-09-23 2006-08-15 Applied Genetics Technologies Corporation High titer recombinant AAV production
US7427396B2 (en) 2004-06-03 2008-09-23 Genzyme Corporation AAV vectors for gene delivery to the lung
CN100348718C (zh) * 2005-10-18 2007-11-14 中国人民解放军军事医学科学院生物工程研究所 一种支持hek293细胞贴附培养的无动物来源成分无血清培养基
ES2533863T3 (es) * 2007-06-29 2015-04-15 Korea Research Institute Of Chemical Technology Inhibidores novedosos de la transcriptasa inversa de VIH

Also Published As

Publication number Publication date
TWI608102B (zh) 2017-12-11
KR20150103275A (ko) 2015-09-09
MX360470B (es) 2018-11-05
EP2943567A1 (en) 2015-11-18
CN105008523A (zh) 2015-10-28
JP6837094B2 (ja) 2021-03-03
WO2014110053A1 (en) 2014-07-17
SG11201505333PA (en) 2015-08-28
BR112015016328B1 (pt) 2023-04-18
MX2015008861A (es) 2016-04-13
RU2018144779A3 (no) 2022-03-02
EP3266866A1 (en) 2018-01-10
HUE037482T2 (hu) 2018-08-28
IL239824B (en) 2019-03-31
AU2014205604A1 (en) 2015-08-13
BR122020002822B1 (pt) 2023-04-18
EP3266866B1 (en) 2019-03-06
BR112015016328A2 (no) 2017-09-05
RU2018144779A (ru) 2019-01-29
AU2014205604B2 (en) 2020-01-02
IL239824A0 (en) 2015-08-31
SG10201806715TA (en) 2018-09-27
US20150353899A1 (en) 2015-12-10
RU2676733C2 (ru) 2019-01-10
US20220340883A1 (en) 2022-10-27
DK2943567T3 (en) 2018-01-02
EP2943567B1 (en) 2017-09-13
TW201446965A (zh) 2014-12-16
JP2019187420A (ja) 2019-10-31
JP2016504913A (ja) 2016-02-18
KR102307279B1 (ko) 2021-09-29
US11299715B2 (en) 2022-04-12
AR094389A1 (es) 2015-07-29
ES2651763T3 (es) 2018-01-29
CA2897444A1 (en) 2014-07-17
HK1249544A1 (zh) 2018-11-02
JP6534933B2 (ja) 2019-06-26
SG10201913130PA (en) 2020-03-30
RU2015133205A (ru) 2017-02-14
EP3521420A1 (en) 2019-08-07
CN105008523B (zh) 2020-03-27
HK1214840A1 (zh) 2016-08-05

Similar Documents

Publication Publication Date Title
AP2016009275A0 (no)
BR112016012521A2 (no)
BR112016005372A2 (no)
BR112015007533A2 (no)
BR112014018502A2 (no)
BR112014019326A2 (no)
BR112014018516A2 (no)
BR112014020341A2 (no)
BR112014018480A2 (no)
BR112014017855A2 (no)
BR112014021878A2 (no)
BR112015029139A2 (no)
BR112016009209A2 (no)
BR112016012133A2 (no)
BR112014018468A2 (no)
BR112014019204A2 (no)
NO3050055T3 (no)
BR112014017653A2 (no)
BR112015015948A2 (no)
BR112014018578A2 (no)
BR112014018483A2 (no)
BR112014017794A2 (no)
BR112016000629A2 (no)
BR112014018496A2 (no)
BR112014017601A2 (no)